MLL MUNCHNER LEUKAMIELABOR GMBH - Germany 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 13.119.520 552.788 2
2020 0 6.715.625 54.000 1
2017 0 20.200.000 199.766 1
2012 0 5.870.815 587.082 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITA DEGLI STUDI DI TORINO4
UNIVERSITY OF BOLOGNA4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS3
MASARYKOVA UNIVERZITA3
UNIVERSITAET ULM3
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE2
CELGENE MANAGEMENT SARL2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION2
EUROPEAN HEMATOLOGY ASSOCIATION2
EUROPEAN RESEARCH INITIATIVE ON CLL EV2
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS2
FUNDACION HOSPITAL LA FE2
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON2
GENOME RESEARCH2
GMV SOLUCIONES GLOBALES INTERNET SAU2
GPOH GEMEINNUTZIGE2
GROUPE FRANCOPHONE DES MYELODYSPLASIES2
ISOFT SANIDAD2
LEUKANET EV2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MEDISAPIENS OY2
MENARINI RICERCHE2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
NOVARTIS PHARMA2
OSPEDALE PEDIATRICO BAMBINO GESU2
STICHTING VUMC2
STIFTUNG ELN FOUNDATION2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
THE LYMPHOMA STUDY ASSOCIATION2
UNIVERSIDAD DE NAVARRA2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF NEWCASTLE UPON TYNE2
VIB VZW2
ABBVIE INC1
AMGEN1
AUSTRALO INTERINNOV MARKETING LAB SL1
BARTS AND THE LONDON NHS TRUST1
BAYER1
BAYER PHARMA1
BIOBAM BIOINFORMATICS SL1
CENTRE DE REGULACIO GENOMICA1
CHAMBRE DE COMMERCE ET D'INDUSTRIE DE REGION PARIS ILEDEFRANCE1
CONSORZIO INTERUNIVERSITARIO PER LA GESTIONE DEL CENTRO DI CALCOLO ELETTRONICO DELL'ITALIA NORD ORIENTALE1
DATAWIZARD1
DH HEALTHCARE PROVIDER SOFTWARE SPAIN SLU1
DXC TECHNOLOGY SERVICIOS ESPANA SL1
ENTERPRISE SOLUTIONS CONSULTORIA Y APLICACIONES1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
FASTERIS1
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION DE INVESTIGACION DEL CANCER DE LA UNIVERSIDAD DE SALAMANCA1
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT1
GERENCIA REGIONAL DE SALUD DE CASTILLA Y LEON1
GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HUMANITAS MIRASOLE1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
IRCCS AZIENDA OSPEDALIERO UNIVERSITARIA DI BOLOGNA1
ISTITUTO NAZIONALE DI FISICA NUCLEARE1
JANSSEN PHARMACEUTICA NV1
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN1
KYPRIAKO IDRYMA EREVNON GIA TI MYIKI DISTROFIA1
LIFE TECHNOLOGIES1
LYSARC1
MEDIZINISCHE UNIVERSITAET WIEN1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
PERSONAL GENOMICS1
PFIZER LIMITED1
SINAPTICA IT1
TAKEDA DEVELOPMENT CENTRE EUROPE1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA1
UNIVERSIDAD POLITECNICA DE MADRID1
UNIVERSITA DEGLI STUDI DI FIRENZE1
UNIVERSITA DEGLI STUDI DI PADOVA1
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA1
UNIVERSITAET LEIPZIG1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITY OF BERGEN1
UNIVERSITY OF CAMBRIDGE1
UNIVERSITY OF COPENHAGEN1
UNIVERSITY OF YORK1
VETERINAERMEDIZINISCHE UNIVERSITAET WIEN1

Constancy:

Total number of partners: 137
Partner loyalty:
Frequent Partner: (> 2 projects): 20
Rare Partner: 117
Frequent / Rare Partner Ratio: 0.17

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Exploring cell-to-cell heterogeneity and exploiting epigenetic regulation for the interception of myeloid disease cells. INTERCEPT-MDSparticipant3.120.45610
2021-01-01Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases GenoMed4ALLparticipant9.999.06428
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2012-11-01Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia NGS-PTLparticipant5.870.81510